NCT00198354View on ClinicalTrials.gov

Stage I/II NSCLC Perioperative Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions
Non-small Cell Lung Cancer Stage I and IIPeri-operative Chemotherapy
Interventions
DRUG

gemcitabine + cisplatine

gemcitabine 1250 mg/m², D1+D8 cisplatine 80 mg/m², D1 (D1=D22)

DRUG

Paclitaxel + Carboplatine

paclitaxel 200 mg/m², D1 carboplatin AUC 6, D1 (D1=D22)

Trial Locations (1)

25000

CHU Besancon - Pneumologie, Besançon

All Listed Sponsors
lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER

NCT00198354 - Stage I/II NSCLC Perioperative Chemotherapy | Biotech Hunter | Biotech Hunter